JP2012526738A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012526738A5 JP2012526738A5 JP2012510162A JP2012510162A JP2012526738A5 JP 2012526738 A5 JP2012526738 A5 JP 2012526738A5 JP 2012510162 A JP2012510162 A JP 2012510162A JP 2012510162 A JP2012510162 A JP 2012510162A JP 2012526738 A5 JP2012526738 A5 JP 2012526738A5
- Authority
- JP
- Japan
- Prior art keywords
- oil
- water emulsion
- mometasone
- emulsion according
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 21
- 239000007764 o/w emulsion Substances 0.000 claims 21
- 229960001664 mometasone Drugs 0.000 claims 13
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 8
- -1 mometasone furan carboxylic acid esters Chemical class 0.000 claims 7
- 239000003995 emulsifying agent Substances 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000000839 emulsion Substances 0.000 claims 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 5
- 239000008158 vegetable oil Substances 0.000 claims 5
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 239000006071 cream Substances 0.000 claims 3
- 239000003002 pH adjusting agent Substances 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 229940073610 elocon Drugs 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 229960003511 macrogol Drugs 0.000 claims 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 235000019198 oils Nutrition 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 claims 1
- 229930186217 Glycolipid Natural products 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 235000019486 Sunflower oil Nutrition 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000005215 alkyl ethers Chemical class 0.000 claims 1
- 239000000828 canola oil Substances 0.000 claims 1
- 235000019519 canola oil Nutrition 0.000 claims 1
- 229940082500 cetostearyl alcohol Drugs 0.000 claims 1
- 239000003240 coconut oil Substances 0.000 claims 1
- 235000019864 coconut oil Nutrition 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 239000002600 sunflower oil Substances 0.000 claims 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200900601 | 2009-05-12 | ||
| DKPA200900601 | 2009-05-12 | ||
| PCT/EP2010/002921 WO2010130428A1 (en) | 2009-05-12 | 2010-05-12 | Oil-in-water emulsion of mometasone and propylene glycol |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015142118A Division JP2015227354A (ja) | 2009-05-12 | 2015-07-16 | モメタゾンとプロピレングリコールとの水中油型エマルジョン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012526738A JP2012526738A (ja) | 2012-11-01 |
| JP2012526738A5 true JP2012526738A5 (enExample) | 2013-06-27 |
| JP5833541B2 JP5833541B2 (ja) | 2015-12-16 |
Family
ID=42352732
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012510162A Active JP5833541B2 (ja) | 2009-05-12 | 2010-05-12 | モメタゾンとプロピレングリコールとの水中油型エマルジョン |
| JP2015142118A Pending JP2015227354A (ja) | 2009-05-12 | 2015-07-16 | モメタゾンとプロピレングリコールとの水中油型エマルジョン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015142118A Pending JP2015227354A (ja) | 2009-05-12 | 2015-07-16 | モメタゾンとプロピレングリコールとの水中油型エマルジョン |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8728497B2 (enExample) |
| EP (2) | EP2962688B1 (enExample) |
| JP (2) | JP5833541B2 (enExample) |
| CN (1) | CN102458382B (enExample) |
| AU (1) | AU2010246613B2 (enExample) |
| BR (1) | BRPI1010907B8 (enExample) |
| CA (1) | CA2761739C (enExample) |
| CY (1) | CY1116667T1 (enExample) |
| DK (1) | DK2429510T3 (enExample) |
| ES (2) | ES2813400T3 (enExample) |
| HR (1) | HRP20150959T1 (enExample) |
| HU (1) | HUE027718T2 (enExample) |
| MX (1) | MX345888B (enExample) |
| NZ (1) | NZ596429A (enExample) |
| PL (2) | PL2962688T3 (enExample) |
| PT (1) | PT2429510E (enExample) |
| RU (1) | RU2526911C2 (enExample) |
| SI (1) | SI2429510T1 (enExample) |
| SM (1) | SMT201500297B (enExample) |
| WO (1) | WO2010130428A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1010907B8 (pt) | 2009-05-12 | 2021-05-25 | Galenica Ab | emulsão de óleo-em-água de mometasona e propileno-glicol |
| PT105982B (pt) * | 2011-11-03 | 2014-07-29 | Laboratório Edol Produtos Farmac Uticos S A | Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios |
| JP7262227B2 (ja) * | 2017-10-23 | 2023-04-21 | マルホ株式会社 | 被膜形成外用剤 |
| US20190282465A1 (en) * | 2018-03-19 | 2019-09-19 | Essential Lipid Technologies, LLC | Topical Phospholipid Formulations and Methods for Preparing the Same |
| CN120500342A (zh) | 2022-12-20 | 2025-08-15 | 格林尼卡皮肤股份公司 | 用于局部皮肤治疗的新的组合物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4282216A (en) * | 1977-04-20 | 1981-08-04 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
| US4808610A (en) | 1986-10-02 | 1989-02-28 | Schering Corporation | Mometasone furoate anti-inflammatory cream composition using hexylene glycol |
| US5422361A (en) * | 1989-12-20 | 1995-06-06 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| WO1994013257A1 (en) * | 1992-12-16 | 1994-06-23 | Creative Products Resource Associates, Ltd. | Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
| US5696105A (en) * | 1996-03-14 | 1997-12-09 | Hackler; Walter A. | Antifungal nail composition |
| US5952003A (en) * | 1996-08-01 | 1999-09-14 | Novartis Corporation | Terazosin capsules |
| US6075056A (en) | 1997-10-03 | 2000-06-13 | Penederm, Inc. | Antifungal/steroid topical compositions |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| US7030203B2 (en) * | 2001-09-28 | 2006-04-18 | 3M Innovative Properties Company | Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| AR038628A1 (es) * | 2002-03-04 | 2005-01-19 | Novartis Ag | Composicion oftalmica |
| TR200201343A2 (tr) | 2002-05-17 | 2003-12-22 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve antiseptik içeren farmasötik bileşim |
| MXPA05002248A (es) | 2002-08-27 | 2005-06-08 | Schering Corp | Procedimiento para producir formulaciones de inhalador de dosis medida. |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20060104968A1 (en) * | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| WO2004105686A2 (en) | 2003-05-23 | 2004-12-09 | Taro Pharmaceuticals U.S.A., Inc. | Novel topical steroid cream formulations |
| EP1631290A2 (en) | 2003-05-23 | 2006-03-08 | Combinatorx, Incorporated | Combination therapy for the treatment of neoplasms |
| US20050196462A1 (en) * | 2003-12-30 | 2005-09-08 | Oculus Innovative Sciences, Inc. | Topical formulation containing oxidative reductive potential water solution and method for using same |
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| DE102006034883A1 (de) | 2006-07-25 | 2008-01-31 | Hermal Kurt Herrmann Gmbh & Co. Ohg | Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat |
| EP2120868A4 (en) | 2007-04-11 | 2010-08-25 | Perrigo Israel Phamaceuticals | LOW-DOSED MOMETASON FORMULATIONS |
| DK2429490T3 (en) | 2009-05-12 | 2017-02-20 | Galenica Ab | OIL-IN-WATER EMULSION OF MOMETASON |
| BRPI1010907B8 (pt) | 2009-05-12 | 2021-05-25 | Galenica Ab | emulsão de óleo-em-água de mometasona e propileno-glicol |
-
2010
- 2010-05-12 BR BRPI1010907A patent/BRPI1010907B8/pt active IP Right Grant
- 2010-05-12 PT PT107216970T patent/PT2429510E/pt unknown
- 2010-05-12 SI SI201031007T patent/SI2429510T1/sl unknown
- 2010-05-12 EP EP15172934.0A patent/EP2962688B1/en active Active
- 2010-05-12 CN CN201080030169.1A patent/CN102458382B/zh active Active
- 2010-05-12 HU HUE10721697A patent/HUE027718T2/en unknown
- 2010-05-12 ES ES15172934T patent/ES2813400T3/es active Active
- 2010-05-12 DK DK10721697.0T patent/DK2429510T3/en active
- 2010-05-12 NZ NZ596429A patent/NZ596429A/xx not_active IP Right Cessation
- 2010-05-12 RU RU2011150246/15A patent/RU2526911C2/ru active
- 2010-05-12 US US13/319,758 patent/US8728497B2/en active Active
- 2010-05-12 ES ES10721697.0T patent/ES2547556T3/es active Active
- 2010-05-12 AU AU2010246613A patent/AU2010246613B2/en active Active
- 2010-05-12 JP JP2012510162A patent/JP5833541B2/ja active Active
- 2010-05-12 PL PL15172934T patent/PL2962688T3/pl unknown
- 2010-05-12 HR HRP20150959TT patent/HRP20150959T1/hr unknown
- 2010-05-12 PL PL10721697T patent/PL2429510T3/pl unknown
- 2010-05-12 CA CA2761739A patent/CA2761739C/en active Active
- 2010-05-12 EP EP10721697.0A patent/EP2429510B1/en active Active
- 2010-05-12 WO PCT/EP2010/002921 patent/WO2010130428A1/en not_active Ceased
- 2010-05-12 MX MX2011011959A patent/MX345888B/es active IP Right Grant
-
2014
- 2014-02-24 US US14/187,997 patent/US11395827B2/en active Active
-
2015
- 2015-07-16 JP JP2015142118A patent/JP2015227354A/ja active Pending
- 2015-09-03 CY CY20151100770T patent/CY1116667T1/el unknown
- 2015-11-30 SM SM201500297T patent/SMT201500297B/it unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100849537B1 (ko) | 코엔자임 큐텐의 나노에멀젼 조성물 | |
| JP2012526738A5 (enExample) | ||
| PH12016500100B1 (en) | Self-emulsifying composition of omega3 fatty acid | |
| FI3360575T3 (fi) | Ihon kautta annosteltavat farmaseuttiset koostumukset, jotka käsittävät vaikuttavia aineita | |
| CA2907721A1 (en) | Compositions and methods for topical delivery of prostaglandins to subcutaneous fat | |
| RU2006120468A (ru) | Система доставки с контролируемым высвобождением для назального применения | |
| EP2638903A4 (en) | SUPPRESSOR FOR INCREASING THE BLOOD SUGAR MIRROR | |
| JP2013507337A5 (enExample) | ||
| JP2012524771A5 (enExample) | ||
| JP2015531377A5 (enExample) | ||
| WO2010030824A1 (en) | Gelatinous elastomer compositions | |
| RU2016150868A (ru) | Пероральная фармацевтическая композиция изотретиноина | |
| KR102702557B1 (ko) | 디아세레인 또는 레인 국소 제형 및 이의 용도 | |
| CA2929865C (en) | Sprayable topical carrier and composition comprising phosphatidylcholine | |
| JP2012505867A5 (enExample) | ||
| HRP20230726T1 (hr) | Topikalna formulacija za poticanje zarastanja rana | |
| JP2013525485A5 (enExample) | ||
| WO2012083138A3 (en) | Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds | |
| NZ600358A (en) | Topical foam composition | |
| RU2013126259A (ru) | Фармацевтическая композиция таксоидов | |
| EP1938785A3 (de) | Kosmetische und dermatologische Öl-in-Wasser-Emulsionen mit selbstkonservierenden Eigenschaften | |
| FI4082524T3 (fi) | Triatsiiniformulaatioita | |
| CN103479595B (zh) | 一种含有度他雄胺的软胶囊 | |
| WO2011121034A3 (en) | Water-free pharmaceutical compositions suitable for local anaesthetics | |
| RU2011150246A (ru) | Эмульсия "масло-в-воде" моментазона и пропиленгликоля |